Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith Y Smith

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The American Journal of Drug and Alcohol Abuse|July 26, 2006
Clinician validation of Poison Control Center (PCC) intentional exposure cases involving prescription opioidsMeredith Y Smith, Richard Dart, Alice Hughes, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 16, 2007
Quantifying morbidity associated with the abuse and misuse of opioid analgesics: a comparison of two approachesMeredith Y Smith, Michael F Schneider, Alicia Wentz, et al.
Drug Safety|March 13, 2025
Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative BlueprintMeredith Y Smith, Rachel Davis, Priya Bahri, et al.
International Journal of Epidemiology|June 28, 2021
The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standardsMeredith Y Smith, Priya Bahri, James A Gaudino, et al.
Drug and Alcohol Dependence|October 21, 2005
Association between non-medical and prescriptive usage of opioidsNabarun Dasgupta, E Douglas Kramer, Mary-Ann Zalman, et al.
Journal of Managed Care & Specialty Pharmacy|August 3, 2015
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims AnalysisMeredith Y Smith, Meritxell Sabidó-Espin, Anton Trochanov, et al.
Journal of Pain and Symptom Management|October 27, 2004
Acceptable, manageable, and tolerable days: patient daily goals for medication management of persistent painDiane C Zelman, Meredith Y Smith, Deborah Hoffman, et al.
Drug Safety|December 9, 2017
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal ProductsMeredith Y Smith, Andrea Russell, Priya Bahri, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products"Meredith Y Smith, Tarek A Hammad, Marilyn Metcalf, et al.
Drug Safety|October 5, 2013
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidanceAnjan K Banerjee, Sally Okun, I Ralph Edwards, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The American Journal of Drug and Alcohol Abuse|July 26, 2006
Clinician validation of Poison Control Center (PCC) intentional exposure cases involving prescription opioidsMeredith Y Smith, Richard Dart, Alice Hughes, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 16, 2007
Quantifying morbidity associated with the abuse and misuse of opioid analgesics: a comparison of two approachesMeredith Y Smith, Michael F Schneider, Alicia Wentz, et al.
Drug Safety|March 13, 2025
Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative BlueprintMeredith Y Smith, Rachel Davis, Priya Bahri, et al.
International Journal of Epidemiology|June 28, 2021
The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standardsMeredith Y Smith, Priya Bahri, James A Gaudino, et al.
Drug and Alcohol Dependence|October 21, 2005
Association between non-medical and prescriptive usage of opioidsNabarun Dasgupta, E Douglas Kramer, Mary-Ann Zalman, et al.
Journal of Managed Care & Specialty Pharmacy|August 3, 2015
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims AnalysisMeredith Y Smith, Meritxell Sabidó-Espin, Anton Trochanov, et al.
Journal of Pain and Symptom Management|October 27, 2004
Acceptable, manageable, and tolerable days: patient daily goals for medication management of persistent painDiane C Zelman, Meredith Y Smith, Deborah Hoffman, et al.
Drug Safety|December 9, 2017
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal ProductsMeredith Y Smith, Andrea Russell, Priya Bahri, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products"Meredith Y Smith, Tarek A Hammad, Marilyn Metcalf, et al.
Drug Safety|October 5, 2013
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidanceAnjan K Banerjee, Sally Okun, I Ralph Edwards, et al.
Pageof 5